In summary, this pan-cancer analysis demonstrated that increased ENO1 expression was correlated with poor prognosis and decreased immune infiltration levels in macrophages, CD4+ T cells, CD8+ T cells, and B cells in CESC and LUAD. The gene discussed is ENO1; the disease is cancer.